COO and CFO
Fri, Aug 15, 2025
Aug 15
2,250 shares @ $0.00
Decreased holdings by -16.70%
Net across this filing: +4.80% (+12,769 shares)
51st largest trade (out of 143)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +4.8% (+12,769 shares)
69% win rate · +5.4% median edge vs SPY (13 trades, 90-day · small sample)
Price 29% below 200-day moving average
Small Cap stock — insider trades carry more weight
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology